Publication date: May 22, 2026
Compared with prepandemic patients, those hospitalized during and after the pandemic peak were older. Nevertheless, they write, their findings underscore the need for ongoing surveillance and further study to better understand who is most at risk for myocarditis in the post-pandemic period. During the pandemic, hospitalizations climbed sharply, reaching 103 cases in 2020, 128 in 2021, and 139 in 2022, for an increase of roughly 80% above baseline.
| Concepts | Keywords |
|---|---|
| Biopsy | Baseline |
| Diabetes | Covid |
| Viral | Covid19 |
| Welldescribed | Higher |
| Hospital | |
| Hospitalizations | |
| Hospitalized | |
| Increased | |
| Infection | |
| Myocarditis | |
| Note | |
| Pandemic | |
| Peak | |
| Prepandemic | |
| Rates |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Tropicamide |
| disease | MESH | infection |
| disease | MESH | viral infection |
| disease | MESH | inflammation |
| disease | MESH | COVID-19 |
| disease | MESH | Myocarditis |
| disease | MESH | multiple chronic conditions |
| disease | MESH | injury |
| disease | MESH | chronic kidney disease |
| disease | MESH | obesity |
| disease | MESH | hyperlipidemia |
| disease | MESH | hypertension |
| pathway | REACTOME | Immune System |
Original Article
(Visited 3 times, 1 visits today)